INDICATION: Melanoma...
BCIQ Company Profiles
Boston University School of Medicine
Shandong University
University of Oxford
BCIQ Target Profiles
Lysophospholipase 2 (LYPLA2)
Melanocortin 1 receptor (MC1R)
Zinc finger DHHC-type containing 13 (ZDHHC13)